iData’s U.S. neurology devices market MedSuite covers 14 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
In 2020, the global neuromodulation device market size was valued at nearly $4.4 billion, with over 230,000 neuromodulation procedures performed every year. The neuromodulation devices market growth is expected to be around 7.6% allowing the market size to approach $7.3 billion in 2026. Throughout this medical market research, we analyzed 13 neuromodulation device companies across
iData’s global neurology devices market MedSuite covers 15 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
iData’s European neurology devices market MedSuite covers 14 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
This report analyzes the procedure volumes that relate to neurological devices in Europe from 2013-2023. This data includes segmentation on Cerebro-spinal Fluid Shunting Procedures, Neurovascular Embolization Procedures, Intracranial Stenting Procedures, Neurovascular Guidewire Procedures and Neuromodulation Procedures.
An aneurysm clip is a permanent fixture in the brain that resembles a tiny coil-spring clothespin made of titanium or a cobalt chromium nickel alloy. Biocompatible aneurysm clips used in the neurosurgical field are available in a variety of shapes and sizes, with known closing pressures. Aneurysm clips are placed at the neck of an aneurysm and serve to isolate the thin-walled aneurysm from arterial flow without obstructing the parent artery or other perforating arteries. Aneurysms are a localized, blood-filled balloon-bulge in the wall of a blood vessel. As an aneurysm grows, it becomes thinner and more prone to leaking or rupture. If this occurs, blood is released into the spaces around the brain, leading to a subarachnoid hemorrhage (SAH).
Balloon occlusion devices have inflatable balloon devices at their distal end which can be expanded to occlude an artery. Balloon occlusion devices serve a number of purposes in neurovascular procedures. They can be used to assist detachable coil procedures, similarly to stents, however these devices are temporary. In these cases they are being used to aid in the treatment of aneurysms, AVMs or fistulas. When using detachable coils there is a risk of the coils blocking flow of the parent artery if they occlude the lumen of the artery as well. In order to minimize this risk, the balloon is inflated inside the parent artery prior to the insertion of coils so that they can be packed tighter inside the aneurysm without the danger of them protruding into the lumen. A study looking at this technique in anterior aneurysms found that there was a lower complication rate with balloon assisted coiling in comparison to coiling alone however other studies have found the opposite therefore further studies are required. In some cases, balloon catheters can also be used for the placement of stents. There are a number of factors that could impact the choice to use this device for aneurysm treatment such as the clinical situation, physicians preference, and the morphology of the aneurysm. It is worth noting that the ASP of these devices is considerably less than stents which could impact device preference as well.
Devices in the cerebrospinal fluid (CSF) management market are mainly used for the treatment of hydrocephalus. Hydrocephalus, or water on the brain, refers to an abnormal buildup of CSF in the brains ventricles. Under normal biological conditions, equilibrium between the production, circulation and absorption of CSF is maintained in the ventricular cavities of the brain as CSF is continually drained away into the circulatory system. Hydrocephalus can result when absorption of fluid into the bloodstream is blocked which leads to an accumulation of CSF. This condition can result in increased intracranial pressure inside of the skull and can lead to tunnel vision, mental disability, progressive enlargement of the head and even death. Symptoms due to the increased intracranial pressure include headaches, nausea, vomiting, papilledema, coma or sleepiness. Further elevation of intracranial pressure can result in uncal and/or cerebellar herniation.
Detachable coil embolization is a minimally invasive method of treating brain aneurysms and cerebral blood vessel malformations. The detachable coil embolization treatment of cerebral aneurysms is less invasive and requires less recovery time than open surgery. An aneurysm is a weakened area in the wall of an artery in the brain. This area bulges in the artery and if it ruptures it can lead to a bleed in the brain and cause stroke, brain damage and even death. Interventional neuroradiologists will typically perform the detachable coil embolization process to alleviate dangers associated with aneurysms.
An intrathecal pump is an implantable medical device that delivers medication to the intrathecal space surrounding the spinal cord. The drug pump reduces the reliance of patients on oral or intravenous medications and can minimize the associated side effects while controlling their symptoms. Lower doses of medications are generally required since the drug delivery is more targeted. Before a pump is implanted into the patient, the therapeutic effect of the intrathecal opioid therapy is tested with an external pump; the pump is not implanted if there are no clear and satisfactory effects in the trial application.
Liquid embolics currently on the market include N-butyl cyanoacrylate (NBCA) (TRUFILL®) and an ethylene-vinyl alcohol copolymer (Onyx®). These agents are injected through microcatheters and act like glue in abnormal blood vessels. When they contact blood they solidify and obstruct the vessel lumen therefore blocking the flow of blood through malformed blood vessels and reducing the risk of rupture. The surgeon performing the procedure must flush the catheter before and after injecting the NBCA to prevent the liquid agent from sticking to the catheter. Thus this procedure requires a highly skilled physician. This is often done prior to the removal of these vessels in order to simplify the surgical procedure.
Neuroendoscopy is a rapidly expanding field of neurosurgery. Neuroendoscopy involves the use of a small fiber-optic camera attached to an endoscope that is a few millimeters in diameter. Neuroendoscopes combine high quality fiberoptic images with flexible and steerable designs that allow neurosurgeons to visualize their target deep within the brain without disrupting other vital structures. In order to transmit extremely accurate images to the neurosurgeon, there have been innovative advances in lens design and optical physics over the last decade. Smaller fiberoptic scopes with improved image quality, as well as three-dimensional imaging, have contributed to advancements within this market. An endoscope can also be utilized with or without stereotactic techniques.
Optical microscopy is an increasingly technical field in which light from an area of interest is passed through lenses to provide a magnified view. Neurosurgical microscopes have many requirements such as extreme precision, outstanding color conformity, high resolution image quality, efficient light transmission, exceptional detail within the field of view and ergonomic use, all of which increase surgical accuracy and decrease physician fatigue. Leica has produced a 3D heads-up system which saves surgeons from having to look through the oculars of the microscope for long portions of the day.
Ultrasonic aspirators are used to remove unwanted tissue that is adjacent or attached to vital structures in a minimally invasive fashion. By converting electrical energy into high-frequency sonic waves, ultrasonic aspirators break down soft tissues through vibration in order to preserve surrounding fibrous tissue while simultaneously irrigating and aspirating the area. Ultrasonic aspirators are designed to maximize selectivity of tissue to give the neurosurgeon greater control. Neurosurgeons can use ultrasonic aspirators to remove tumors in hard-to-reach areas by cavitation. Tissues with moderate or high fluid content are easiest to fragment, like tumors, parenchyma and fat. However, most devices on the market today have the capability to also break down tougher tissues, such as fine bones.
This report analyzes the procedure volumes for neurological device markets in the US between 2013 and 2023. Segmentation includes 8 main segments: Cerebrospinal Fluid Shunting Procedures, Lumbar Shunting Procedures, Neurovascular Embolization Procedures, Neuromodulation Procedures, Spinal Cord Stimulator Procedures, Deep Brain Stimulator Procedures, Peripheral Nerve Stimulator Procedures, Vagus, Sacral and Gastric Nerve Stimulator Implementation Procedures, Aneurysm Clipping Procedures, Intrathecal Pump Procedures and Intracranial Neuroendoscopic Procedures